Inhibitory effects of a maleimide compound on the virulence factors of Candida albicans

References

• McCarty TP, White CM, Pappas PG. Candidemia and invasive candidiasis. Infect Dis Clin North Am. 2021;35(2):389–17. doi: 10.1016/j.idc.2021.03.007
   PubMed Web of Science ®Google Scholar
• Jeffery-Smith A, Taori SK, Schelenz S, et al. Candida auris: a review of the literature. Clin Microbiol Rev. 2018;31(1). doi: 10.1128/CMR.00029-17
   PubMed Web of Science ®Google Scholar
• Tong Y, Tang J. Candida albicans infection and intestinal immunity. Microbiol Res. 2017;198:27–35. doi: 10.1016/j.micres.2017.02.002
   PubMedGoogle Scholar
• An Y, Dong Y, Liu M, et al. Novel naphthylamide derivatives as dual-target antifungal inhibitors: design, synthesis and biological evaluation. Eur J Med Chem. 2021;210:112991. doi: 10.1016/j.ejmech.2020.112991
   PubMed Web of Science ®Google Scholar
• Pristov KE, Ghannoum MA. Resistance of Candida to azoles and echinocandins worldwide. Clin Microbiol Infect. 2019;25(7):792–798. doi: 10.1016/j.cmi.2019.03.028
   PubMed Web of Science ®Google Scholar
• Dahiya S, Sharma N, Punia A, et al. Antimycotic drugs and their mechanisms of resistance to Candida species. Curr Drug Targets. 2022;23(2):116–125. doi: 10.2174/1389450122666210719124143
   PubMed Web of Science ®Google Scholar
• Gioia F, Gomez-Lopez A, Alvarez ME, et al. Pharmacokinetics of echinocandins in suspected Candida peritonitis: a potential risk for resistance. Int J Infect Dis. 2020;101:24–28. doi: 10.1016/j.ijid.2020.09.019
   PubMed Web of Science ®Google Scholar
• Sortino M, Cechinel Filho V, Corrêa R, et al. N-Phenyl and N-phenylalkyl-maleimides acting against Candida spp.: time-to-kill, stability, interaction with maleamic acids. Bioorgan Med Chem. 2008;16(1):560–568. doi: 10.1016/j.bmc.2007.08.030
   PubMed Web of Science ®Google Scholar
• Bhagare AM, Aher JS, Gaware MR, et al. Novel Schiff bases derived from N-aryl maleimide derivatives as an effective antimicrobial agent: the oretical and experimental approach. Bioorg Chem. 2020;103:104129. doi: 10.1016/j.bioorg.2020.104129
   PubMed Web of Science ®Google Scholar
• CLSI (2020). Clinical and Laboratory Standards Institute Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts CLSI Document M44. 3rd ed (Wayne, PA: Clinical and Laboratory Standards Institute;). Available at: https://clsi.org/standards/products/microbiology/documents/m44/
   Google Scholar
• Song M, Zhang M, Lu J, et al. Palmarumycin P3 reverses mrr1-mediated azole resistance by blocking the efflux pump Mdr1. Antimicrob Agents Chemother. 2022;66(3):e0212621. doi: 10.1128/aac.02126-21
   PubMed Web of Science ®Google Scholar
• Chang W, Li Y, Zhang L, et al. Retigeric acid B enhances the efficacy of azoles combating the virulence and biofilm formation of Candida albicans. Biol Pharm Bull. 2012;35(10):1794–1801. doi: 10.1248/bpb.b12-00511
   PubMed Web of Science ®Google Scholar
• Wang M, Gu K, Ding W, et al. Antifungal effect of a new photosensitizer derived from BODIPY on Candida albicans biofilms. Photodiagn Photodyn. 2022;39:102946. doi: 10.1016/j.pdpdt.2022.102946
   PubMed Web of Science ®Google Scholar
• Biniarz P, Baranowska G, Feder-Kubis J, et al. The lipopeptides pseudofactin II and surfactin effectively decrease Candida albicans adhesion and hydrophobicity. Anton leeuw int j g. 2015;108(2):343–353. doi: 10.1007/s10482-015-0486-3
   PubMed Web of Science ®Google Scholar
• Li Y, Shan M, Yan M, et al. Anticandidal activity of kalopanaxsaponin a: effect on proliferation, cell morphology, and key virulence attributes of Candida albicans. Front Microbiol. 2019;10:2844. doi: 10.3389/fmicb.2019.02844
   PubMed Web of Science ®Google Scholar
• Li Y, Chang W, Zhang M, et al. Natural product solasodine-3-O-β-D-glucopyranoside inhibits the virulence factors of Candida albicans. FEMS Yeast Res. 2015;15(6):fov060. doi: 10.1093/femsyr/fov060
   PubMed Web of Science ®Google Scholar
• Zhang L, Chang W, Sun B, et al. Bisbibenzyls, a new type of antifungal agent, inhibit morphogenesis switch and biofilm formation through upregulation of DPP3 in Candida albicans. PLoS One. 2011;6(12):e28953. doi: 10.1371/journal.pone.0028953
   PubMed Web of Science ®Google Scholar
• Wu XZ, Cheng AX, Sun LM, et al. Effect of plagiochin E, an antifungal macrocyclic bis(bibenzyl), on cell wall chitin synthesis in Candida albicans. Acta Pharmacol Sin. 2008;29(12):1478–1485. doi: 10.1111/j.1745-7254.2008.00900.x
   PubMed Web of Science ®Google Scholar
• Li Y, Chang W, Zhang M, et al. Diorcinol D exerts fungicidal action against Candida albicans through cytoplasm membrane destruction and ROS accumulation. PLoS One. 2015;10(6):e0128693. doi: 10.1371/journal.pone.0128693
   PubMed Web of Science ®Google Scholar
• Duan X, Xie Z, Ma L, et al. Selective metal chelation by a thiosemicarbazone derivative interferes with mitochondrial respiration and ribosome biogenesis in Candida albicans. Microbiol Spectr. 2022;10(3):e0195121. doi: 10.1128/spectrum.01951-21
   PubMed Web of Science ®Google Scholar
• Girardot M, Millot M, Hamion G, et al. Lichen polyphenolic compounds for the eradication of Candida albicans biofilms. Front Cell Infect Microbiol. 2021;11(null):698883. doi: 10.3389/fcimb.2021.698883
   PubMedGoogle Scholar
• Sanglard D, Odds FC. Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect Dis. 2002;2(2):73–85. doi: 10.1016/s1473-3099(02)00181-0
   PubMed Web of Science ®Google Scholar
• Ardizzoni A, Boaretto G, Pericolini E, et al. Effects of benzydamine and mouthwashes containing benzydamine on Candida albicans adhesion, biofilm formation, regrowth, and persistence. Clin Oral Invest. 2022;26(4):3613–3625. doi: 10.1007/s00784-021-04330-8
   PubMed Web of Science ®Google Scholar
• Qiu L, Zhang TS, Song JZ, et al. BbWor1, a regulator of morphological transition, is involved in conidium-hypha switching, blastospore propagation, and virulence in Beauveria bassiana. Microbiol Spectr. 2021;9(1):e0020321. doi: 10.1128/Spectrum.00203-21
   PubMed Web of Science ®Google Scholar
• Kanchanapiboon J, Kongsa U, Pattamadilok D, et al. Boesenbergia rotunda extract inhibits Candida albicans biofilm formation by pinostrobin and pinocembrin. J Ethnopharmacol. 2020;261:113193. doi: 10.1016/j.jep.2020.113193
   PubMed Web of Science ®Google Scholar
• Honorato L, de Araujo JFD, Ellis CC, et al. Extracellular vesicles regulate biofilm formation and yeast-to-hypha differentiation in Candida albicans. MBio. 2022;13(3):e0030122. doi: 10.1128/mbio.00301-22
   PubMed Web of Science ®Google Scholar
• Chen M, Cheng T, Xu C, et al. Sodium houttuyfonate enhances the mono-therapy of fluconazole on oropharyngeal candidiasis (OPC) through HIF-1α/IL-17 axis by inhibiting cAMP mediated filamentation in Candida albicans-Candida glabrata dual biofilms. Virulence. 2022;13(1):428–443. doi: 10.1080/21505594.2022.2035066
   PubMed Web of Science ®Google Scholar
• Lee JH, Kim YG, Khadke SK, et al. Antibiofilm and antifungal activities of medium-chain fatty acids against Candida albicans via mimicking of the quorum-sensing molecule farnesol. Microbiol Biotechnol. 2021;14(4):1353–1366. doi: 10.1111/1751-7915.13710
   Google Scholar
• Liu RH, Shang ZC, Li TX, et al. In Vitro Antibiofilm Activity of Eucarobustol E against Candida albicans. Antimicrob Agents Ch. 2017;61(8). doi: 10.1128/AAC.02707-16
   Web of Science ®Google Scholar
• Pukkila-Worley R, Ausubel FM, Mylonakis E, et al. Candida albicans infection of Caenorhabditis elegans induces antifungal immune defenses. PLOS Pathog. 2011;7(6):e1002074. doi: 10.1371/journal.ppat.1002074
   PubMed Web of Science ®Google Scholar
• Wang B, Wang Y, Zhang L, et al. Surveillance study of epidemiology, antifungal susceptibility and risk factors of invasive candidiasis in critically ill Patients. Clin Lab. 2022;68(6/2022). doi: 10.7754/Clin.Lab.2021.211001
   Web of Science ®Google Scholar
• Hoenigl M, Sprute R, Arastehfar A, et al. Invasive candidiasis: investigational drugs in the clinical development pipeline and mechanisms of action. Expert Opin Inv Drug. 2022;31(8):1–18. doi: 10.1080/13543784.2022.2086120
   PubMed Web of Science ®Google Scholar
• Fan Y, Lu Y, Chen X, et al. Anti-leishmanial and cytotoxic activities of a series of maleimides: synthesis, biological evaluation and structure-activity relationship. Molecules. 2018;23(11):2878. doi: 10.3390/molecules23112878
   PubMed Web of Science ®Google Scholar
• Mayer FL, Wilson D, Hube B. Candida albicans pathogenicity mechanisms. Virulence. 2013;4(2):119–128. doi: 10.4161/viru.22913
   PubMed Web of Science ®Google Scholar
• McCall AD, Pathirana RU, Prabhakar A, et al. Candida albicans biofilm development is governed by cooperative attachment and adhesion maintenance proteins. NPJ Biofilms Microbiomes. 2019;5(1):21. doi: 10.1038/s41522-021-00264-x
   PubMedGoogle Scholar
• Fu Y, Ibrahim AS, Sheppard DC, et al. Candida albicans Als1p: an adhesin that is a downstream effector of the EFG1 filamentation pathway. Mol Microbiol. 2002;44(1):61–72. doi: 10.1046/j.1365-2958.2002.02873.x
   PubMed Web of Science ®Google Scholar
• Zhao X, Oh SH, Cheng G, et al. ALS3 and ALS8 represent a single locus that encodes a Candida albicans adhesin; functional comparisons between Als3p and Als1p. Microbiol-sgm. 2004;150(7):2415–2428. doi: 10.1099/mic.0.26943-0
   PubMedGoogle Scholar
• Ene IV, Bennett RJ. Hwp1 and related adhesins contribute to both mating and biofilm formation in Candida albicans. Eukaryot Cell. 2009;8(12):1909–1913. doi: 10.1128/EC.00245-09
   PubMedGoogle Scholar
• Kumar A. The complex genetic basis and multilayered regulatory control of yeast pseudohyphal growth. Ann Rev Genet. 2021;55(1):1–21. doi: 10.1146/annurev-genet-071719-020249
   PubMedGoogle Scholar
• Naglik JR, Moyes DL, Wächtler B, et al. Candida albicans interactions with epithelial cells and mucosal immunity. Microbes Infect. 2011;13(12–13):963–976. doi: 10.1016/j.micinf.2011.06.009
   PubMed Web of Science ®Google Scholar
• Mitchell AP. Microbiology: fungus produces a toxic surprise. Nature. 2016;532(7597):41–42. doi: 10.1038/nature17319
   PubMed Web of Science ®Google Scholar
• Antinori S, Milazzo L, Sollima S, et al. Candidemia and invasive candidiasis in adults: a narrative review. Eur J Intern Med. 2016;34:21–28. doi: 10.1016/j.ejim.2016.06.029
   PubMed Web of Science ®Google Scholar
• Chen H, Zhou X, Ren B, et al. The regulation of hyphae growth in Candida albicans. Virulence. 2020;11(1):337–348. doi: 10.1080/21505594.2020.1748930
   PubMed Web of Science ®Google Scholar
• Nobile CJ, Mitchell AP. Genetics and genomics of Candida albicans biofilm formation. Cell Microbiol. 2006;8(9):1382–1391. doi: 10.1111/j.1462-5822.2006.00761.x
   PubMed Web of Science ®Google Scholar
• Zarnowski R, Noll A, Chevrette MG, et al. Coordination of fungal biofilm development by extracellular vesicle cargo. Nat Commun. 2021;12(1):6235. doi: 10.1038/s41467-021-26525-z
   PubMed Web of Science ®Google Scholar
• Monniot C, Boisramé A, Da Costa G, et al. Rbt1 protein domains analysis in Candida albicans brings insights into hyphal surface modifications and Rbt1 potential role during adhesion and biofilm formation. PLoS One. 2013;8(12):e82395. doi: 10.1371/journal.pone.0082395
   PubMed Web of Science ®Google Scholar
• Song P, Peng G, Yue H, et al. Candidalysin, a virulence factor of candida albicans, stimulates mast cells by mediating cross-talk between signaling pathways activated by the dectin-1 receptor and MAPKs. J Clin Immunol. 2022;42(5):1009–1025. doi: 10.1007/s10875-022-01267-9
   PubMed Web of Science ®Google Scholar
• Huang G, Huang Q, Wei Y, et al. Multiple roles and diverse regulation of the Ras/cAMP/protein kinase a pathway in Candida albicans. Mol Microbiol. 2019;111(1):6–16. doi: 10.1111/mmi.14148
   PubMed Web of Science ®Google Scholar
• Hornby JM, Kebaara BW, Nickerson KW. Farnesol biosynthesis in Candida albicans: cellular response to sterol inhibition by zaragozic acid B. Antimicrob Agents Ch. 2003;47(7):2366–2369. doi: 10.1128/AAC.47.7.2366-2369.2003
   PubMed Web of Science ®Google Scholar
• Navarathna DHMLP, Hornby JM, Krishnan N, et al. Effect of farnesol on a mouse model of systemic candidiasis, determined by use of a DPP3 knockout mutant of Candida albicans. Infect Immun. 2007;75(4):1609–1618. doi: 10.1128/IAI.01182-06
   PubMed Web of Science ®Google Scholar
• Hisajima T, Maruyama N, Tanabe Y, et al. Protective effects of farnesol against oral candidiasis in mice. Microbiol Immunol. 2008;52(7):327–333. doi: 10.1111/j.1348-0421.2008.00044.x
   PubMed Web of Science ®Google Scholar
• Kruppa M, Krom BP, Chauhan N, et al. The two-component signal transduction protein Chk1p regulates quorum sensing in Candida albicans. Eukaryot Cell. 2004;3(4):1062–1065. doi: 10.1128/EC.3.4.1062-1065.2004
   PubMedGoogle Scholar
• Nagy F, Vitális E, Jakab Á, et al. In vitro and in vivo effect of exogenous farnesol exposure against Candida auris. Front Microbiol. 2020;11(null):957. doi: 10.3389/fmicb.2020.00957
   PubMedGoogle Scholar
• Mosel DD, Dumitru R, Hornby JM, et al. Farnesol concentrations required to block germ tube formation in Candida albicans in the presence and absence of serum. Appl Environ Microb. 2005;71(8):4938–4940. doi: 10.1128/AEM.71.8.4938-4940.2005
   PubMed Web of Science ®Google Scholar
• Abe S, Tsunashima R, Iijima R, et al. Suppression of anti-Candida activity of macrophages by a quorum-sensing molecule, farnesol, through induction of oxidative stress. Microbiol Immunol. 2009;53(6):323–330. doi: 10.1111/j.1348-0421.2009.00128.x
   PubMed Web of Science ®Google Scholar
• Jemel S, Guillot J, Kallel K, et al. Galleria mellonella for the evaluation of antifungal efficacy against medically important fungi, a narrative review. Microorganisms. 2020;8(3):390. null. doi: 10.3390/microorganisms8030390
   PubMed Web of Science ®Google Scholar